Search

Author/Creator Oldenburg, J.

22. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVBonn) associated with activated protein C resistance. (13th June 2016)

Authors:
Pezeshkpoor, B.; Castoldi, E.; Mahler, A.; Hanel, D.; Müller, J.; Hamedani, N. S.; Biswas, A.; Oldenburg, J.; Pavlova, A.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 14:Number 7(2016:Jul.)
Page Start:
1353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. In silico calculated affinity of FVIII‐derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene. (14th October 2013)

Authors:
Pashov, A. D.; Calvez, T.; Gilardin, L.; Maillère, B.; Repessé, Y.; Oldenburg, J.; Pavlova, A.; Kaveri, S. V.; Lacroix‐Desmazes, S.
Journal:
Haemophilia
Issue:
Volume 20:Number 2(2014:Mar.)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. In silico calculated affinity of FVIII‐derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene. (14th October 2013)

Authors:
Pashov, A. D.; Calvez, T.; Gilardin, L.; Maillère, B.; Repessé, Y.; Oldenburg, J.; Pavlova, A.; Kaveri, S. V.; Lacroix‐Desmazes, S.
Journal:
Haemophilia
Issue:
Volume 20:Number 2(2014:Mar.)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Inhibitor development and mortality in non‐severe hemophilia A. (10th June 2015)

Authors:
Eckhardt, C. L.; Loomans, J. I.; van Velzen, A. S.; Peters, M.; Mauser‐Bunschoten, E. P.; Schwaab, R.; Mazzucconi, M. G.; Tagliaferri, A.; Siegmund, B.; Reitter‐Pfoertner, S. E.; van der Bom, J. G.; Fijnvandraat, K.; the INSIGHT Study Group; Fijnvandraat, K.; Peters, M.; Kamphuisen, P. W.; Kamphu...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 13:Number 7(2015:Jul.)
Page Start:
1217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. Inhibitor development and mortality in non‐severe hemophilia A. (10th June 2015)

Authors:
Eckhardt, C. L.; Loomans, J. I.; van Velzen, A. S.; Peters, M.; Mauser‐Bunschoten, E. P.; Schwaab, R.; Mazzucconi, M. G.; Tagliaferri, A.; Siegmund, B.; Reitter‐Pfoertner, S. E.; van der Bom, J. G.; Fijnvandraat, K.; the INSIGHT Study Group; Fijnvandraat, K.; Peters, M.; Kamphuisen, P. W.; Kamphu...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 13:Number 7(2015:Jul.)
Page Start:
1217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. (13th June 2016)

Authors:
Lentz, S. R.; Cerqueira, M.; Janic, D.; Kempton, C.; Matytsina, I.; Misgav, M.; Oldenburg, J.; Ozelo, M.; Recht, M.; Rosholm, A.; Savic, A.; Suzuki, T.; Tiede, A.; Santagostino, E.
Journal:
Haemophilia
Issue:
Volume 22:Number 5(2016:Sep.)
Page Start:
e445
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗